Biopharma

Toward a More Proactive Health Care System

Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.

For Pharmaceutical Companies, Three Steps to Value with Generative AI

New GenAI offerings can benefit virtually every aspect of an organization, boosting efficiency and productivity in areas ranging from R&D to commercial activities.

How Biopharma Can Make a Difference in Health Equity

By leveraging innovative business models and partnerships, biopharma companies could reach patients in low- and middle-income countries at no extra cost.

The Inflation Reduction Act’s Ripple Effects on the US Health Care Ecosystem

The IRA provisions concerning the pricing of drugs for Medicare patients are creating new economic realities for health care players.

A Strategic Approach to Cost in Biopharma

Manufacturing costs are rising rapidly, with no end in sight. Leaders that balance the various tradeoffs can remain competitive over the long run.

Bold Advances in Health Care

Biogen’s CFO on Leading a People-First Transformation

Mike McDonnell explains how the global biotech is charting new paths to patientsvia Fit for Growth, its corporate transformation initiative.

Pfizer’s Digital Transformation

Chief Digital and Technology Officer Lidia Fonseca explains how Pfizer is leveraging digital and data across the value chain and the biggest wins so far.

CEO Paul Hudson on Sanofi’s Climate Ambition

Hudson discusses the company’s commitment to reaching net zero emissions by 2045.

CEO Richard Francis on the Talent Behind Teva’s Success

Francis discusses the role that Teva’s people are playing in the execution of the company’s new growth strategy.

Health Care Payers, Providers, Systems, and Services

Practical Steps for Health Care Leaders in the Era of Generative AI

The technology is evolving rapidly, but five simple steps can help providers capitalize on GenAI to improve performance, reduce costs, and enhance the experience for patients and staff.

Facing Headwinds, Health Systems Can Learn from Airlines

To thrive during turbulent economic times, health systems can learn from the aviation industry, which embraced novel diversification approaches to maintain revenue stability and improve profitability.

BCG-WEF Project: Digital Health Care Transformation

While digital, data, and AI have extraordinary potential to revolutionize our global health care systems, they have yet to deliver a transformative impact. How can the public and private sectors accelerate progress?

Are Payers and Providers Ready for Digital Change in Health Care?

The latest technologies hold tremendous promise for health care, but they also pose significant challenges. Not all organizations are prepared to take advantage of the tech trends.

Medical Devices and Technology

Medtech’s Path to a Circular Future

Most environmental waste generated by the health care sector comes from medtech products. For a sector focused on improving quality of life, reducing waste and greenhouse gases is imperative.

Medtech Companies Must Move Faster on Generative AI

To realize the promise and potential for GenAI, medtech executives must make swift and targeted efforts.

Medtech’s New Era of Collaboration and Innovation

Medtech management teams face an unfamiliar list of questions. The players that can successfully navigate the challenging terrain will be the winners of the 2020s.

Medtech’s Generative AI Opportunity

The technology has a range of uses in medtech, and the main challenge is knowing how and where to start. Here are 60 ways to generate quick wins.

Global Health

Addressing Challenges at the Intersection of Climate and Health

BCG conducted a study of more than 70 organizations—including philanthropies, multilateral development banks, government agencies, nongovernmental organizations, private sector actors, and others—to understand how key stakeholders are approaching the climate-health challenge.

Human Health Depends on Planetary Health

Too often is it taken for granted that the environment is a massive determinant of human well-being. Putting health at the center of our climate discussions is critical.

Embedding Health Equity into the Heart of Biopharma

The biopharma industry faces demands for more action to address health inequities. We provide a guide and tools to help companies integrate equity across the product lifecycle.

Reimagining Global Health After the Coronavirus

What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?

• 

  Anticipating the Spread of COVID-19 with Scenario Planning

  BCG’s scenario-planning tool, PLAN, helps you explore the potential impact of COVID-19 in the United States at a region, state, and county level.
• 

  BD’s Vincent Forlenza on Transforming in a Rapidly Changing Industry

  Vincent Forlenza, CEO of BD, has navigated multibillion-dollar acquisitions while driving a full-scale organizational transformation. BD’s success, amid enormous change, hinges on its purpose-driven culture.
• 

  Karalee Close on The Digital Opportunity in Healthcare

  Using digital to harness the next generation of science and the exponential growth of health care data.
• 

  Accelerating Drug Development Today

  Sit in on a conversation with BCG pharma leaders as they discuss advancing drug development with new tools, real-world data, digitization, and collaboration across cross-functional teams.
• 

  Using Big Data to Measure Health Care Outcomes

  According to BCG's Sanjay Saxena, the opportunity for using big data and analytics in measuring outcomes is huge. But the trick for payers and providers will be understanding the data—and knowing which questions to ask about it.
• 

  Jon Kaplan on Health Care Payers

  BCG’s Jon Kaplan explains how health care payers can provide the strongest portfolio of product offerings and best service in today’s marketplace.